Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha1-adrenergic receptor activity	ADRA1D ADRA1B ADRA1A	3.91e-07	3	147	3	GO:0004937
GeneOntologyMolecularFunction	alpha-adrenergic receptor activity	ADRA1D ADRA1B ADRA1A	7.69e-06	6	147	3	GO:0004936
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	ABR DENND2D ECT2 RIN1 SBF2 RABGEF1 FGD5 RAPGEF2 DOCK6 PLCE1	8.42e-06	231	147	10	GO:0005085
GeneOntologyMolecularFunction	GTPase binding	IQGAP2 RAB11FIP2 RILPL1 ECT2 GRIP1 RIN1 DIAPH2 RABGEF1 FGD5 MLPH IPO11 PLCE1	1.49e-05	360	147	12	GO:0051020
GeneOntologyMolecularFunction	small GTPase binding	IQGAP2 RAB11FIP2 RILPL1 ECT2 RIN1 DIAPH2 RABGEF1 FGD5 MLPH IPO11 PLCE1	2.65e-05	321	147	11	GO:0031267
GeneOntologyMolecularFunction	adrenergic receptor activity	ADRA1D ADRA1B ADRA1A	4.52e-05	10	147	3	GO:0004935
GeneOntologyMolecularFunction	G protein-coupled amine receptor activity	CHRM3 ADRA1D ADRA1B ADRA1A	2.31e-04	41	147	4	GO:0008227
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ABR IQGAP2 DENND2D ECT2 RGS1 RIN1 SBF2 RABGEF1 FGD5 RAPGEF2 DOCK6 PLCE1	3.80e-04	507	147	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ABR IQGAP2 DENND2D ECT2 RGS1 RIN1 SBF2 RABGEF1 FGD5 RAPGEF2 DOCK6 PLCE1	3.80e-04	507	147	12	GO:0030695
GeneOntologyMolecularFunction	ionotropic glutamate receptor binding	GRIA2 GRIP1 DLG1 CACNG4	5.80e-04	52	147	4	GO:0035255
GeneOntologyBiologicalProcess	neuron-glial cell signaling	ADRA1D ADRA1B ADRA1A	3.23e-06	5	143	3	GO:0150099
GeneOntologyBiologicalProcess	regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback	ADRA1D ADRA1B ADRA1A	6.43e-06	6	143	3	GO:0001978
GeneOntologyBiologicalProcess	positive regulation of blood pressure by epinephrine-norepinephrine	ADRA1D ADRA1B ADRA1A	1.12e-05	7	143	3	GO:0003321
GeneOntologyBiologicalProcess	regulation of systemic arterial blood pressure by norepinephrine-epinephrine	ADRA1D ADRA1B ADRA1A	1.78e-05	8	143	3	GO:0001993
GeneOntologyBiologicalProcess	regulation of systemic arterial blood pressure by baroreceptor feedback	ADRA1D ADRA1B ADRA1A	1.78e-05	8	143	3	GO:0003025
GeneOntologyBiologicalProcess	nervous system process involved in regulation of systemic arterial blood pressure	CHRM3 ADRA1D ADRA1B ADRA1A	2.11e-05	24	143	4	GO:0001976
GeneOntologyBiologicalProcess	adenylate cyclase-activating adrenergic receptor signaling pathway	ADRA1D ADRA1B ADRA1A RAPGEF2	2.50e-05	25	143	4	GO:0071880
GeneOntologyBiologicalProcess	diacylglycerol metabolic process	DGKG DGKD PLPP1 PLCE1	3.98e-05	28	143	4	GO:0046339
GeneOntologyBiologicalProcess	adrenergic receptor signaling pathway	ADRA1D ADRA1B ADRA1A RAPGEF2	9.81e-05	35	143	4	GO:0071875
GeneOntologyBiologicalProcess	positive regulation of smooth muscle contraction	SRF ITGA2 CHRM3 ADRA1A	1.10e-04	36	143	4	GO:0045987
GeneOntologyBiologicalProcess	cellular response to brain-derived neurotrophic factor stimulus	GRIA2 GRIP1 DLG1	1.12e-04	14	143	3	GO:1990416
GeneOntologyBiologicalProcess	regulation of GTPase activity	ABR IQGAP2 RAB11FIP2 ECT2 RGS1 FGD5 PRKG1 RAPGEF2 DOCK6 EPHA4	1.18e-04	335	143	10	GO:0043087
GeneOntologyBiologicalProcess	norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure	ADRA1D ADRA1A	1.43e-04	3	143	2	GO:0001994
GeneOntologyBiologicalProcess	baroreceptor response to increased systemic arterial blood pressure	ADRA1D ADRA1A	1.43e-04	3	143	2	GO:0001983
GeneOntologyBiologicalProcess	protein kinase C signaling	MAS1 DGKG DGKD ADRA1A	1.84e-04	41	143	4	GO:0070528
GeneOntologyBiologicalProcess	regulation of smooth muscle contraction	SRF ITGA2 CHRM3 ADRA1A PRKG1	2.23e-04	79	143	5	GO:0006940
GeneOntologyBiologicalProcess	positive regulation of heart rate by epinephrine-norepinephrine	ADRA1B ADRA1A	2.84e-04	4	143	2	GO:0001996
GeneOntologyBiologicalProcess	positive regulation of the force of heart contraction by epinephrine-norepinephrine	ADRA1B ADRA1A	2.84e-04	4	143	2	GO:0001997
GeneOntologyBiologicalProcess	multicellular organismal locomotion	COL6A1 DIAPH2	2.84e-04	4	143	2	GO:0071965
GeneOntologyBiologicalProcess	phospholipase C-activating G protein-coupled receptor signaling pathway	GPR33 CHRM3 ADRA1D ADRA1B ADRA1A PLCE1	3.33e-04	133	143	6	GO:0007200
GeneOntologyBiologicalProcess	smooth muscle contraction	SRF ITGA2 CHRM3 ADRA1A DLG1 PRKG1	3.33e-04	133	143	6	GO:0006939
GeneOntologyBiologicalProcess	regulation of protein kinase C signaling	DGKG DGKD ADRA1A	3.41e-04	20	143	3	GO:0090036
GeneOntologyBiologicalProcess	double-strand break repair	MEAF6 ERCC5 XRCC5 TRRAP ESCO2 OTUB2 SMARCD2 SMARCD3 DNTT	4.41e-04	324	143	9	GO:0006302
GeneOntologyBiologicalProcess	nucleosome disassembly	ATAD2B SMARCD2 SMARCD3	4.56e-04	22	143	3	GO:0006337
GeneOntologyBiologicalProcess	negative regulation of protein kinase C signaling	DGKG DGKD	4.71e-04	5	143	2	GO:0090038
GeneOntologyBiologicalProcess	positive regulation of the force of heart contraction by chemical signal	ADRA1B ADRA1A	4.71e-04	5	143	2	GO:0003099
GeneOntologyCellularComponent	spine synapse	GRIA2 GRIP1	4.91e-05	2	147	2	GO:0106033
GeneOntologyCellularComponent	sarcolemma	COL6A1 STAC RYR3 ADRA1B ADRA1A DLG1 CACNG4 PRKG1	6.10e-05	190	147	8	GO:0042383
GeneOntologyCellularComponent	T-tubule	STAC ADRA1B ADRA1A DLG1 CACNG4	2.38e-04	79	147	5	GO:0030315
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	MEAF6 KANSL1L TRRAP MCRS1	2.80e-04	45	147	4	GO:1902562
GeneOntologyCellularComponent	MPP7-DLG1-LIN7 complex	DLG1 MPP7	4.84e-04	5	147	2	GO:0097025
MousePheno	impaired smooth muscle contractility	CHRM3 ADRA1B ADRA1A DLG1 PRKG1	1.18e-05	35	121	5	MP:0000740
Pathway	REACTOME_ADRENOCEPTORS	ADRA1D ADRA1B ADRA1A	3.26e-05	9	105	3	M27302
Pathway	REACTOME_ADRENOCEPTORS	ADRA1D ADRA1B ADRA1A	3.26e-05	9	105	3	MM15009
Pathway	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	GRIA2 GRIP1 DLG1 CACNG4	5.98e-05	29	105	4	MM15028
Pathway	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	GRIA2 GRIP1 DLG1 CACNG4	7.83e-05	31	105	4	M7223
Pathway	WP_MONOAMINE_GPCRS	CHRM3 ADRA1D ADRA1B ADRA1A	7.83e-05	31	105	4	MM15871
Pathway	WP_MONOAMINE_GPCRS	CHRM3 ADRA1D ADRA1B ADRA1A	1.01e-04	33	105	4	M39585
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	CHRM3 ADRA1D ADRA1B ADRA1A	2.62e-04	42	105	4	M5868
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	CHRM3 ADRA1D ADRA1B ADRA1A	2.62e-04	42	105	4	MM14971
Pathway	REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	ABR ECT2 ADRA1D ADRA1B ADRA1A	2.69e-04	77	105	5	MM15044
Pathway	REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	ABR ECT2 ADRA1D ADRA1B ADRA1A	3.22e-04	80	105	5	M800
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	GPR33 MAS1 CHRM3 ADRA1D ADRA1B ADRA1A P2RY14	4.77e-04	186	105	7	MM15994
Pathway	KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY	CHRM3 ADRA1D ADRA1B ADRA1A	5.14e-04	50	105	4	M47951
Pubmed	Yeast two-hybrid screening for proteins that interact with alpha1-adrenergic receptors.	ABR ADRA1D ADRA1B ADRA1A	4.69e-09	6	148	4	15525470
Pubmed	Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	19259685
Pubmed	Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	17973108
Pubmed	Examination of alpha 1 adrenoceptor subtypes in the human ureter.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	17681068
Pubmed	Molecular cloning of alpha 1d-adrenergic receptor and tissue distribution of three alpha 1-adrenergic receptor subtypes in mouse.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	7595531
Pubmed	Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	12595294
Pubmed	Functional role of α1-adrenoceptor subtypes in murine ophthalmic arteries.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	21613371
Pubmed	Up-regulation of α1-adrenoceptors in burn and keloid scars.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	29089212
Pubmed	Role of α1-adrenoceptor subtypes on corneal epithelial thickness and cell proliferation in mice.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	30257104
Pubmed	Differential regulation of the cell cycle by alpha1-adrenergic receptor subtypes.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	15297446
Pubmed	The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	8183249
Pubmed	Blockade of both alpha1A- and alpha1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	17384126
Pubmed	Role of α₁-adrenoceptor subtypes in pupil dilation studied with gene-targeted mice.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	25425303
Pubmed	Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	8024574
Pubmed	Alpha1-adrenoceptors are required for normal male sexual function.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	17603545
Pubmed	The alpha(1B)-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	14659805
Pubmed	The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	23877383
Pubmed	Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	7815325
Pubmed	Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	18257748
Pubmed	Specific interactions between gC1qR and alpha1-adrenoceptor subtypes.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	14626446
Pubmed	Neuron-glia signaling via alpha(1) adrenoceptor-mediated Ca(2+) release in Bergmann glial cells in situ.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	10493741
Pubmed	alpha 1-Adrenergic receptor subtypes differentially control the cell cycle of transfected CHO cells through a cAMP-dependent mechanism involving p27Kip1.	ADRA1D ADRA1B ADRA1A	7.55e-08	3	148	3	12409310
Pubmed	Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays.	ADRA1D ADRA1B ADRA1A	3.01e-07	4	148	3	32085899
Pubmed	The stimulatory effects of alpha1-adrenergic receptors on TGF-beta1, IGF-1 and hyaluronan production in human skin fibroblasts.	ADRA1D ADRA1B ADRA1A	7.50e-07	5	148	3	24844469
Pubmed	Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells.	ADRA1D ADRA1B ADRA1A	1.50e-06	6	148	3	12184796
Pubmed	α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells.	ADRA1D ADRA1B ADRA1A	1.50e-06	6	148	3	28862946
Pubmed	Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes.	ADRA1D ADRA1B ADRA1A	1.50e-06	6	148	3	17636168
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	DSC3 RAB11FIP2 ITGA2 GRIP1 USP31 PTPN13 MAP4K5 SEC23IP DLG1 MPP7 EPHA4	2.08e-06	421	148	11	36976175
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RPL27A ABR DSC3 HSPH1 GART XRCC5 GRIP1 PTPN13 TCERG1 MAP4K5 SEC23IP DLG1 EIF3G MPP7	2.21e-06	708	148	14	39231216
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	RAB11FIP2 SCYL3 DGKD TRRAP BIRC6 USP31 CNNM4 RIN1 ADRA1B PTPN13 SEC23IP DLG1 SMARCD2 MLPH	2.64e-06	719	148	14	35337019
Pubmed	Human transcription factor protein interaction networks.	MEAF6 RPL27A INTS12 HDAC5 HSPH1 UBR4 RRP15 POU2F1 GTPBP1 XRCC5 TRRAP TFDP2 OTUB2 FAM120A TCERG1 SMARCD2 SMARCD3 MCRS1 EIF3G LAS1L	3.00e-06	1429	148	20	35140242
Pubmed	Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers.	CHRM3 ADRA1D ADRA1B ADRA1A	3.72e-06	25	148	4	19855129
Pubmed	Cardiac function in genetically engineered mice with altered adrenergic receptor signaling.	ADRA1D ADRA1B ADRA1A	4.16e-06	8	148	3	9139936
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL27A RPL38 DDX49 DSC3 POLR2A HSPH1 UBR4 GART RRP15 DGKD XRCC5 ECT2 TRRAP BIRC6 RIN1 FAM120A TCERG1 MAP4K5 LAS1L	5.16e-06	1353	148	19	29467282
Pubmed	Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo.	ADRA1D ADRA1B ADRA1A	6.23e-06	9	148	3	21209093
Pubmed	Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.	ADRA1D ADRA1B ADRA1A	8.87e-06	10	148	3	21063774
Pubmed	Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.	RAB11FIP2 SCYL3 EFHD2 ITGA2 SNX6 SEC23IP DIAPH2 DLG1 EIF3G	1.60e-05	339	148	9	37232246
Pubmed	An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes.	ADRA1B ADRA1A	1.80e-05	2	148	2	17283256
Pubmed	Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II.	POLR2A TCERG1	1.80e-05	2	148	2	10908677
Pubmed	Clinical implications from studies of alpha1 adrenergic receptor knockout mice.	ADRA1D ADRA1B	1.80e-05	2	148	2	17141736
Pubmed	Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors.	ADRA1D ADRA1B	1.80e-05	2	148	2	14736874
Pubmed	Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex.	POLR2A TMEM132D	1.80e-05	2	148	2	29317594
Pubmed	alpha(1)-adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cells.	ADRA1D ADRA1A	1.80e-05	2	148	2	10860850
Pubmed	Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes.	ADRA1B ADRA1A	1.80e-05	2	148	2	18802028
Pubmed	Transcriptional responses to growth factor and G protein-coupled receptors in PC12 cells: comparison of alpha(1)-adrenergic receptor subtypes.	ADRA1D ADRA1B	1.80e-05	2	148	2	10820200
Pubmed	Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.	ADRA1B ADRA1A	1.80e-05	2	148	2	16585965
Pubmed	Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization.	ADRA1B ADRA1A	1.80e-05	2	148	2	12888550
Pubmed	PCIF1, a novel human WW domain-containing protein, interacts with the phosphorylated RNA polymerase II.	POLR2A PCIF1	1.80e-05	2	148	2	12565871
Pubmed	alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse.	ADRA1B ADRA1A	1.80e-05	2	148	2	19540213
Pubmed	The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse.	ADRA1B ADRA1A	1.80e-05	2	148	2	12782680
Pubmed	The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons.	RIN1 EPHA4	1.80e-05	2	148	2	18723684
Pubmed	Dlgh1, a mouse homolog of the drosophila discs-large gene, is located on chromosome 16.	DGKG DLG1	1.80e-05	2	148	2	8678991
Pubmed	Nuclear localization drives α1-adrenergic receptor oligomerization and signaling in cardiac myocytes.	ADRA1B ADRA1A	1.80e-05	2	148	2	22120526
Pubmed	The alpha-1A adrenergic receptor regulates mitochondrial oxidative metabolism in the mouse heart.	ADRA1D ADRA1A	1.80e-05	2	148	2	38331556
Pubmed	[Distribution and significance of α1-adrenoceptor subtypes in patients with chronic prostatitis in prostate, bladder detrusor and posterior urethral tissue].	ADRA1B ADRA1A	1.80e-05	2	148	2	21223784
Pubmed	{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium.	ADRA1B ADRA1A	1.80e-05	2	148	2	19919991
Pubmed	Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor.	GRIA2 GRIP1	1.80e-05	2	148	2	10985351
Pubmed	Differences in the signaling pathways of α(1A)- and α(1B)-adrenoceptors are related to different endosomal targeting.	ADRA1B ADRA1A	1.80e-05	2	148	2	23717684
Pubmed	Threonine-4 of mammalian RNA polymerase II CTD is targeted by Polo-like kinase 3 and required for transcriptional elongation.	POLR2A PLK3	1.80e-05	2	148	2	22549466
Pubmed	Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication.	POLR2A TCERG1	1.80e-05	2	148	2	24165037
Pubmed	Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter.	ADRA1D ADRA1B	1.80e-05	2	148	2	15690361
Pubmed	Abnormal myocardial contraction in alpha(1A)- and alpha(1B)-adrenoceptor double-knockout mice.	ADRA1B ADRA1A	1.80e-05	2	148	2	14519431
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MEAF6 INTS12 HDAC5 IQGAP2 POLR2A UBR4 WRNIP1 POU2F1 ECT2 TRRAP FAM120A HOXC13 TCERG1 MCRS1	1.91e-05	857	148	14	25609649
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	RPL27A POLR2A HSPH1 UBR4 GART WRNIP1 XRCC5 TCERG1 SEC23IP EIF3G LAS1L IPO11	1.98e-05	638	148	12	33239621
Pubmed	Age-dependent blood pressure elevation is due to increased vascular smooth muscle tone mediated by G-protein signalling.	ADRA1D ADRA1B ADRA1A	2.09e-05	13	148	3	26531127
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RPL38 DDX49 INTS12 POLR2A HSPH1 RRP15 EFHD2 DENND2D ECT2 TRRAP C2CD2L PTPN13 GPBP1L1 TCERG1 DLG1 MCRS1 EIF3G LAS1L MPP7	2.12e-05	1497	148	19	31527615
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	HDAC5 RAB11FIP2 BIRC6 GRIP1 PTPN13 RABGEF1 RAPGEF2 DOCK6 MPP7 IPO11	2.30e-05	446	148	10	24255178
Pubmed	Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.	POLR2A SMARCD2 SMARCD3	2.66e-05	14	148	3	8895581
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	HDAC5 TEX2 POLR2A SERPINF1 UBR4 WRNIP1 FAM120A TCERG1 SMARCD2 RAPGEF2	3.91e-05	475	148	10	31040226
Pubmed	Gbx2 is required for the morphogenesis of the mouse inner ear: a downstream candidate of hindbrain signaling.	HMX3 LFNG EPHA4	4.06e-05	16	148	3	15829521
Pubmed	Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross.	POLR2A ADRA1D ADRA1B	4.06e-05	16	148	3	1889803
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL27A SP100 ERCC5 INTS12 IQGAP2 HSPH1 UBR4 DDX42 RRP15 GRIA2 XRCC5 SFMBT2 EFCAB12 SEC23IP DLG1 SMARCD2 MLPH EPHA4	4.41e-05	1442	148	18	35575683
Pubmed	Hyperphosphorylated C-terminal repeat domain-associating proteins in the nuclear proteome link transcription to DNA/chromatin modification and RNA processing.	POLR2A TCERG1	5.38e-05	3	148	2	12376575
Pubmed	GRIP1 regulates synaptic plasticity and learning and memory.	GRIA2 GRIP1	5.38e-05	3	148	2	32948689
Pubmed	Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.	ADRA1B ADRA1A	5.38e-05	3	148	2	18523139
Pubmed	PIKE-mediated PI3-kinase activity is required for AMPA receptor surface expression.	GRIA2 GRIP1	5.38e-05	3	148	2	21847098
Pubmed	GRIP1 is required for homeostatic regulation of AMPAR trafficking.	GRIA2 GRIP1	5.38e-05	3	148	2	26216979
Pubmed	Autonomous expression of aromatase during development of mouse brain is modulated by neurotransmitters.	ADRA1D ADRA1B	5.38e-05	3	148	2	9365205
Pubmed	Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring.	ADRA1B ADRA1A	5.38e-05	3	148	2	16645408
Pubmed	Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex.	ADRA1D ADRA1B	5.38e-05	3	148	2	29426850
Pubmed	Plp1-expresssing perineuronal DRG cells facilitate colonic and somatic chronic mechanical pain involving Piezo2 upregulation in DRG neurons.	POLR2A PIEZO2	5.38e-05	3	148	2	38743566
Pubmed	Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice.	SMARCD2 SMARCD3	5.38e-05	3	148	2	27125315
Pubmed	Gain-of-function glutamate receptor interacting protein 1 variants alter GluA2 recycling and surface distribution in patients with autism.	GRIA2 GRIP1	5.38e-05	3	148	2	21383172
Pubmed	GATA4 is a survival factor in adult cardiac myocytes but is not required for alpha1A-adrenergic receptor survival signaling.	ADRA1B ADRA1A	5.38e-05	3	148	2	18552157
Pubmed	cGMP-dependent protein kinase I beta physically and functionally interacts with the transcriptional regulator TFII-I.	SRF PRKG1	5.38e-05	3	148	2	12082086
Pubmed	PICK1 mediates transient synaptic expression of GluA2-lacking AMPA receptors during glycine-induced AMPA receptor trafficking.	GRIA2 GRIP1	5.38e-05	3	148	2	22915106
Pubmed	Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries.	ADRA1D ADRA1A	5.38e-05	3	148	2	20136833
Pubmed	Structural basis for tandem L27 domain-mediated polymerization.	DLG1 MPP7	5.38e-05	3	148	2	20702775
Pubmed	The AAA+ ATPase Thorase regulates AMPA receptor-dependent synaptic plasticity and behavior.	GRIA2 GRIP1	5.38e-05	3	148	2	21496646
Pubmed	Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.	ADRA1D ADRA1B	5.38e-05	3	148	2	15598970
Pubmed	Human phosphorylated CTD-interacting protein, PCIF1, negatively modulates gene expression by RNA polymerase II.	POLR2A PCIF1	5.38e-05	3	148	2	18294453
Pubmed	Stimulation of phospholipase C-epsilon by the M3 muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B.	CHRM3 PLCE1	5.38e-05	3	148	2	11877431
Pubmed	Transmembrane and ubiquitin-like domain-containing protein 1 (Tmub1/HOPS) facilitates surface expression of GluR2-containing AMPA receptors.	GRIA2 GRIP1	5.38e-05	3	148	2	18665261
Pubmed	Alpha1-adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension.	ADRA1D ADRA1B	5.38e-05	3	148	2	17220188
Pubmed	Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5.	HDAC5 PTPN13	5.38e-05	3	148	2	24191246
Pubmed	Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation.	GRIA2 GRIP1 DLG1	5.88e-05	18	148	3	18311135
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ABR SRF WDR27 RILPL1 XRCC5 TRRAP CHRM3 SFMBT2 CNNM4 PTPN13 FAM120A PLPP1 ZNF587 SBF2 DLG1 RAPGEF2 DOCK6 MLPH	6.65e-05	1489	148	18	28611215
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ABR IQGAP2 UBR4 GRIA2 EFHD2 ARMCX4 XRCC5 FAM120A SEC23IP DIAPH2 DLG1 RABGEF1 RAPGEF2 EPHA4	6.74e-05	963	148	14	28671696
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	POLR2A HSPH1 UBR4 XRCC5 ECT2 BIRC6 OTUB2 ADRA1D ADRA1A ATAD2B PCIF1 PWWP3B	7.84e-05	736	148	12	29676528
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	COL6A1 RPL38 HDAC5 UBR4 RB1CC1 BIRC6 SFMBT2 PTPN13 SEC23IP	8.09e-05	418	148	9	34709266
Interaction	ADRA1A interactions	ABR UBR4 ADRA1D ADRA1B ADRA1A	6.52e-06	37	145	5	int:ADRA1A
GeneFamily	Adrenoceptors	ADRA1D ADRA1B ADRA1A	1.43e-05	9	102	3	169
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKG DGKD	1.38e-03	10	102	2	1178
GeneFamily	VPS9 domain containing	RIN1 RABGEF1	1.38e-03	10	102	2	928
GeneFamily	Sterile alpha motif domain containing	DGKD SFMBT2 SEC23IP EPHA4	1.55e-03	88	102	4	760
GeneFamily	PDZ domain containing	GRIP1 PTPN13 DLG1 RAPGEF2 MPP7	1.70e-03	152	102	5	1220
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 NAALAD2 SERPINF1 AOX1 ADRA1A PIEZO2 NUAK1 PLPP1 PRKG1	1.79e-08	193	148	9	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PIEZO2 NUAK1 PLPP1 APOL3 FGD5 DOCK6	2.14e-08	197	148	9	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 B3GALT5 DCST2 SFMBT2 RYR3 PLCE1	5.18e-08	155	148	8	90e629681a72baacc7981b82883866a487638dbc
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DGKG STAC ADRA1D ADRA1A FBXL22 RERGL SMARCD3 PRKG1	2.29e-07	188	148	8	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR DGKG ADRA1D FBXL22 SMARCD3 P2RY14 PRKG1 PLCE1	2.58e-07	191	148	8	5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR DGKG ADRA1D FBXL22 SMARCD3 P2RY14 PRKG1 PLCE1	2.69e-07	192	148	8	eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 MCTP1 NUAK1 PLPP1 FGD5 EPHA4	2.80e-07	193	148	8	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGKG STAC FBXL22 RERGL SMARCD3 P2RY14 PRKG1 PLCE1	2.80e-07	193	148	8	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGKG STAC FBXL22 RERGL SMARCD3 P2RY14 PRKG1 PLCE1	2.80e-07	193	148	8	0266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 NAALAD2 SERPINF1 AOX1 ADRA1A PIEZO2 PLPP1 PRKG1	2.91e-07	194	148	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PIEZO2 PLPP1 APOL3 FGD5 DOCK6	3.27e-07	197	148	8	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 DCST2 SFMBT2 RYR3 PLCE1	8.95e-07	155	148	7	5a872ca70ae8c30b57f45a6772d7bf565e0c2663
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 DCST2 SFMBT2 RYR3 PLCE1	8.95e-07	155	148	7	e7f49e2fdaf184fa6b4e685518004e7deff1316d
ToppCell	AT1_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	NDNF RILPL1 TMEM132D CACNG4 PWWP3B CTSE PLCE1	1.20e-06	162	148	7	ae2ba4f21f6f6c512006fa531d670b88be7c04c9
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	IQGAP2 MAS1 TRAIP GRIA2 RYR3 RIN1 ADRA1D	1.53e-06	168	148	7	6db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COL6A1 NEK10 MAS1 TRAIP RYR3 PLCXD3 OTULINL	1.53e-06	168	148	7	3fe432267656aff81b6d92c18d1b6fc0cde73d6a
ToppCell	AT1-AT2_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	NDNF WNT9A ITGA2 RILPL1 TMEM132D CACNG4 CTSE	2.01e-06	175	148	7	9a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCell	facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR NEK10 DGKG STAC FBXL22 SMARCD3 PLCE1	2.17e-06	177	148	7	32fecefba1a55e1f418c9a055236fa11175c692d
ToppCell	facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR NEK10 DGKG STAC FBXL22 SMARCD3 PLCE1	2.17e-06	177	148	7	1b153fbfe1323dc589de4af73a52149ea5ce6763
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA2 CHRM3 STAC GRIP1 PTPN13 SMARCD3 PRKG1	2.43e-06	180	148	7	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 IQGAP2 ITGA2 GRIP1 PTPN13 MCTP1 RERGL	2.52e-06	181	148	7	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IQGAP2 DGKD ADRA1B ADRA1A FGD5 CACNG4 PLCE1	2.61e-06	182	148	7	420a8fd30543e37a66ba0786215d056d308660d0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 SFMBT2 RYR3 PTPN13 PLCE1	2.71e-06	183	148	7	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 DGKG DGKD ADRA1D P2RY14 PRKG1 PLCE1	2.71e-06	183	148	7	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 SFMBT2 RYR3 PTPN13 PLCE1	2.71e-06	183	148	7	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 SFMBT2 RYR3 PTPN13 PLCE1	2.71e-06	183	148	7	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 FMOD DGKG ADRA1D P2RY14 PRKG1 PLCE1	2.81e-06	184	148	7	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NDNF INTS12 IQGAP2 SFMBT2 RYR3 PTPN13 PLCE1	2.81e-06	184	148	7	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NDNF GRIP1 ADRA1D ADRA1B ADRA1A FGD5 CACNG4	2.91e-06	185	148	7	4c42bd3cd72f91f4d4ebb849069a03761a2cd662
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FMOD CILP DGKG STAC FBXL22 RERGL PRKG1	3.01e-06	186	148	7	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DGKD GRIP1 ADRA1A PIEZO2 PLCXD3 PRKG1 PLCE1	3.12e-06	187	148	7	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	NBEAL1 DGKG CHRM3 RYR3 PLPP1 PRKG1 MPP7	3.23e-06	188	148	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAALAD2 FMOD EFHD2 P2RY14 PRKG1 RAPGEF2 PLCE1	3.35e-06	189	148	7	26cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 DGKG GRIA2 ADRA1A RERGL PRKG1 PLCE1	3.35e-06	189	148	7	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 DGKG GRIA2 ADRA1A RERGL PRKG1 PLCE1	3.35e-06	189	148	7	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 DGKG GRIA2 ADRA1A RERGL PRKG1 PLCE1	3.35e-06	189	148	7	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 DGKG GRIA2 ADRA1A RERGL PRKG1 PLCE1	3.35e-06	189	148	7	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAB11FIP2 ITGA2 CHRM3 GRIP1 PTPN13 SMARCD3 PRKG1	3.47e-06	190	148	7	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 DGKG ADRA1D P2RY14 PRKG1 DOCK6 PLCE1	3.47e-06	190	148	7	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A1 DCDC2C DGKG STAC ADRA1A PRKG1 PLCE1	3.47e-06	190	148	7	5681c211baeed4af82a2bbc13420f6a7b487581c
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 DGKG ADRA1D P2RY14 PRKG1 DOCK6 PLCE1	3.47e-06	190	148	7	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IQGAP2 DGKD GRIP1 PLCXD3 MINAR1 PRKG1 PLCE1	3.47e-06	190	148	7	8c9c230a509afaeee50644153974a5642b01a2b8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 MCTP1 PLPP1 APOL3 FGD5	3.59e-06	191	148	7	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 AOX1 ITGA2 ADRA1A PIEZO2 NUAK1 PRKG1	3.59e-06	191	148	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PIEZO2 PLPP1 APOL3 FGD5	3.72e-06	192	148	7	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 SERPINF1 AOX1 ADRA1A PIEZO2 PLPP1 PRKG1	3.72e-06	192	148	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DGKD GRIP1 ADRA1B ADRA1A FGD5 CACNG4 PLCE1	3.72e-06	192	148	7	3abee376c37c3646da33ac381aa63d50a01607a6
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	RAB11FIP2 ITGA2 CHRM3 GRIP1 PTPN13 SMARCD3 PRKG1	3.72e-06	192	148	7	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IQGAP2 DGKD ADRA1B ADRA1A FGD5 CACNG4 PLCE1	3.72e-06	192	148	7	6a252e298f8a454623fa9c1c893a7a45a886d694
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 AOX1 ITGA2 ADRA1A PIEZO2 NUAK1 PRKG1	3.72e-06	192	148	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PIEZO2 PLPP1 APOL3 FGD5	3.85e-06	193	148	7	52e918884877b6659cdca0496390e440f73694a9
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SPAST NBEAL1 POU2F1 BIRC6 FAM120A SBF2 DLG1	3.85e-06	193	148	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHRM3 MCTP1 NUAK1 PLPP1 APOL3 FGD5 EPHA4	3.85e-06	193	148	7	6a623acd1adad9a78eddc32ffedb16352ad3fdfa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABR IQGAP2 SFMBT2 MCTP1 SNX6 P2RY14 OTULINL	3.98e-06	194	148	7	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SP100 ABR CHRM3 PIEZO2 PLPP1 FGD5 DOCK6	3.98e-06	194	148	7	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CILP NEK10 DCST2 STAC FBXL22 MINAR1	4.07e-06	126	148	6	e33957cf1541733b06de9f9e7b2801b3d8ae831d
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A1 BRINP3 NAALAD2 PIEZO2 PLPP1 SBF2 PRKG1	4.12e-06	195	148	7	70387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 MCTP1 NUAK1 PLPP1 FGD5	4.12e-06	195	148	7	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL6A1 NAALAD2 AOX1 ADRA1A PIEZO2 NUAK1 PRKG1	4.12e-06	195	148	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 MCTP1 NUAK1 PLPP1 FGD5 EPHA4	4.12e-06	195	148	7	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	ASK440-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	RPL27A RPL38 NBEAL1 PIEZO2 PLPP1 MPP7 IPO11	4.26e-06	196	148	7	833723c8753922374cd7730907f1596899dd5734
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PLPP1 APOL3 FGD5 DOCK6	4.26e-06	196	148	7	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 DGKG ADRA1D P2RY14 PRKG1 OTULINL PLCE1	4.26e-06	196	148	7	8b5337ccf74de90e8b89a02ac00671af1de2cfff
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 DGKG ADRA1D P2RY14 PRKG1 OTULINL PLCE1	4.26e-06	196	148	7	c373465e34e2dd581247962d59e0477aae877079
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PLPP1 APOL3 FGD5 DOCK6	4.26e-06	196	148	7	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 NAALAD2 FMOD CILP SERPINF1 PLCXD3 MPP7	4.40e-06	197	148	7	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|Mesenchymal_cells / Lineage and Cell class	COL6A1 CILP SERPINF1 WNT9A ITIH2 PIEZO2 PLPP1	4.40e-06	197	148	7	cb321836980e7b4efbb9284c6af7ccd34079d2be
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 PIEZO2 PLPP1 APOL3 FGD5 DOCK6	4.55e-06	198	148	7	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PLPP1 APOL3 FGD5 DOCK6	4.55e-06	198	148	7	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PLPP1 APOL3 FGD5 DOCK6	4.55e-06	198	148	7	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABR CHRM3 RYR3 PLPP1 APOL3 FGD5 DOCK6	4.55e-06	198	148	7	07701c73137947ed4a27e225975329235bbb8734
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A1 NAALAD2 SERPINF1 AOX1 NUAK1 PLPP1 PRKG1	4.70e-06	199	148	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A1 ABR DGKG DGKD RERGL P2RY14 PLCE1	4.86e-06	200	148	7	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	Biopsy_IPF-Mesenchymal-Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	COL6A1 BRINP3 FMOD CILP SERPINF1 AOX1 PLPP1	4.86e-06	200	148	7	d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A1 ABR DGKG RERGL P2RY14 PRKG1 PLCE1	4.86e-06	200	148	7	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERCC5 RGS1 PTPN13 DIAPH2 OTULINL CTSE	8.10e-06	142	148	6	58c2882cb0ede8cc5d84c85a650d28267268e748
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKG STAC ADRA1D RERGL SMARCD3 PLCE1	9.50e-06	146	148	6	2ac9b487a7991fdc15444aeb93533030e09825bb
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 GRIA2 ADRA1D RERGL PRKG1 PLCE1	1.20e-05	152	148	6	0cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 GRIA2 ADRA1D RERGL PRKG1 PLCE1	1.20e-05	152	148	6	ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 DGKG ADRA1D RERGL P2RY14 PLCE1	1.39e-05	156	148	6	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 DGKG ADRA1D RERGL P2RY14 PLCE1	1.44e-05	157	148	6	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL6A1 DGKG ADRA1D RERGL IZUMO1 PRKG1	1.49e-05	158	148	6	8d64c0c9de910a3f4658778642d183c8b9b6f6a2
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BRINP3 WNT9A MEI1 ADRA1D NUAK1 EPHA4	1.78e-05	163	148	6	431221a41d396b09170476179590eaf8a55266d8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BRINP3 WNT9A MEI1 ADRA1D NUAK1 EPHA4	1.78e-05	163	148	6	1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8
ToppCell	droplet-Spleen-nan-24m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR27 EFHD2 RGS1 LFNG LRRC9 OTULINL	1.84e-05	164	148	6	7a51365bad2910c130bd952805f7a1bef51be481
ToppCell	Frontal_cortex\|World / BrainAtlas - Mouse McCarroll V32	WNT9A EFHD2 CHRM3 ADRA1B ADRA1A TMEM132D	1.84e-05	164	148	6	e09291711abf8680e78170328313719092b0142f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKG GRIA2 ADRA1A PIEZO2 NUAK1 PRKG1	2.25e-05	170	148	6	cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKG GRIA2 ADRA1A PIEZO2 NUAK1 PRKG1	2.25e-05	170	148	6	99dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKG GRIA2 ADRA1A PIEZO2 NUAK1 PRKG1	2.25e-05	170	148	6	3a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	FAM81B TEX2 RYR3 LRRC9 EFCAB12 CFAP61	2.33e-05	171	148	6	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	NBEAL1 DGKG CHRM3 RERGL PRKG1 PLCE1	2.33e-05	171	148	6	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	COL6A1 DGKG ADRA1D FBXL22 RERGL PRKG1	2.41e-05	172	148	6	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 TEX2 RILPL1 P2RY14 MLPH DNTT	2.41e-05	172	148	6	30916a902c151907745756d14327e24adc34afef
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	COL6A1 DGKG GRIA2 RYR3 FBXL22 PRKG1	2.49e-05	173	148	6	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 DCDC2C DSC3 ADRA1D ADRA1A PLCXD3	2.65e-05	175	148	6	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKG GRIA2 DGKD ADRA1A PRKG1 PLCE1	2.65e-05	175	148	6	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COL6A1 MAS1 RIN1 OTUB2 TMEM132D OTULINL	2.65e-05	175	148	6	c227fc5d1ccb69b82a96a6354913cafaf27d0eec
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKG GRIA2 DGKD ADRA1A PRKG1 PLCE1	2.65e-05	175	148	6	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NDNF GRIP1 ADRA1D ADRA1A PLCXD3 FGD5	2.65e-05	175	148	6	0c648e7f67ffbe3b476a2ca77d246554f8cd1882
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NDNF DGKG ARMCX4 CHRM3 FBXL22 P2RY14	2.74e-05	176	148	6	a8875b4ba4abf6625cdeb67bf544ce1573c59060
Drug	myo-inositol	CMKLR2 RPL38 IQGAP2 TEX2 MAS1 POLR2A SRF DGKG DGKD ITGA2 XRCC5 TRRAP RYR3 ADRA1D ADRA1B ADRA1A PLPP1 P2RY14 PLCXD3 CACNG4 PLCE1	6.95e-08	811	148	21	CID000000892
Drug	1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	ctd:C099060
Drug	Alfuzosin	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	DB00346
Drug	Phenylephrine	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	DB00388
Drug	Dapiprazole	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	DB00298
Drug	2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	ctd:C048008
Drug	Tamsulosin	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	DB00706
Drug	abanoquil	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	ctd:C058534
Drug	ifoxetine	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	CID000071971
Drug	chlorethylclonidine	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	ctd:C051731
Drug	Wy 25309	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	CID000133818
Drug	XB513	ADRA1D ADRA1B ADRA1A	2.69e-07	3	148	3	CID000183813
Drug	tetrabromobisphenol A	FMOD POLR2A HSPH1 WNT9A DGKG B3GALT5 DENND2D LFNG TFDP2 C2CD2L ESCO2 CNNM4 OTUB2 ADRA1D MCTP1 PLPP1 SCUBE3 P2RY14 CTSE PLK3 EPHA4	3.31e-07	891	148	21	ctd:C020806
Drug	tamsulosin	ADRA1D ADRA1B ADRA1A	1.07e-06	4	148	3	ctd:C088482
Drug	sertindole	ADRA1D ADRA1B ADRA1A	1.07e-06	4	148	3	ctd:C066304
Drug	BE 2254	ADRA1D ADRA1B ADRA1A	1.07e-06	4	148	3	ctd:C010652
Drug	5-methylurapidil	ADRA1D ADRA1B ADRA1A	1.07e-06	4	148	3	ctd:C057446
Drug	icodextrin	ABR ESCO2 ADRA1D ADRA1B ADRA1A	1.36e-06	30	148	5	CID000003517
Drug	propiomazine	CHRM3 ADRA1D ADRA1B ADRA1A	1.63e-06	14	148	4	CID000004940
Drug	Promazine	CHRM3 ADRA1D ADRA1B ADRA1A	1.63e-06	14	148	4	DB00420
Drug	Propiomazine	CHRM3 ADRA1D ADRA1B ADRA1A	1.63e-06	14	148	4	DB00777
Drug	Nicardipine	CHRM3 ADRA1D ADRA1B ADRA1A	1.63e-06	14	148	4	DB00622
Drug	Leniquinsin	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000025195
Drug	AC1L9NP0	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000449842
Drug	S-10089	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000146399
Drug	CS-263	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000137303
Drug	5-methylgramine	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000034855
Drug	metazosin	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000093514
Drug	AC1O6ABX	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID006449894
Drug	KABI 2023	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID000192124
Drug	A-53693	ADRA1D ADRA1B ADRA1A	2.67e-06	5	148	3	CID003082713
Drug	Tag Peptide	HSPH1 AOX1 BIRC6 ESCO2	3.82e-06	17	148	4	CID005486959
Drug	Doxazosin	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	DB00590
Drug	Prazosin	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	DB00457
Drug	Br-pindolol	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	CID000125847
Drug	Terazosin	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	DB01162
Drug	Terazosin	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	ctd:C041226
Drug	BMY 7378	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	ctd:C053428
Drug	Xylometazoline	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	DB06694
Drug	alfuzosin	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	ctd:C047638
Drug	dibozane	ADRA1D ADRA1B ADRA1A	5.31e-06	6	148	3	CID000094342
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	COL6A1 DSC3 TRAIP SCYL3 CNNM4 PCIF1 MCRS1 EPHA4 PLCE1	5.89e-06	197	148	9	6317_DN
Drug	Methotrimeprazine	CHRM3 ADRA1D ADRA1B ADRA1A	6.16e-06	19	148	4	DB01403
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	CMKLR2 SP100 ABR TRAIP HSPH1 SCYL3 C2CD2L CNNM4 CACNG4	6.39e-06	199	148	9	1242_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	HDAC5 TRAIP RAB11FIP2 DGKD C2CD2L CNNM4 RIN1 OTUB2 ENTPD5	6.39e-06	199	148	9	6361_DN
Drug	Doxepin	CHRM3 ADRA1D ADRA1B ADRA1A	7.66e-06	20	148	4	DB01142
Drug	naphazoline	ESCO2 ADRA1D ADRA1B ADRA1A	7.66e-06	20	148	4	CID000004436
Drug	Naphazoline	ADRA1D ADRA1B ADRA1A	9.24e-06	7	148	3	ctd:D009278
Drug	xylometazoline	ADRA1D ADRA1B ADRA1A	9.24e-06	7	148	3	ctd:C009695
Drug	3H-DHA	ITGA2 ADRA1D ADRA1B ADRA1A	1.14e-05	22	148	4	CID000129515
Drug	Epinephrine	ADRA1D ADRA1B ADRA1A	1.47e-05	8	148	3	DB00668
Drug	Oxymetazoline	ADRA1D ADRA1B ADRA1A	1.47e-05	8	148	3	ctd:D010109
Drug	tiodazosin	ADRA1D ADRA1B ADRA1A	1.47e-05	8	148	3	CID000060891
Drug	Sertindole	ADRA1D ADRA1B ADRA1A	1.47e-05	8	148	3	DB06144
Drug	nipradilol	ADRA1D ADRA1B ADRA1A PRKG1	1.65e-05	24	148	4	CID000072006
Drug	AC1L1I3V	BIRC6 ADRA1D ADRA1B ADRA1A	1.95e-05	25	148	4	CID000004411
Drug	guanadrel	ADRA1D ADRA1B ADRA1A	2.20e-05	9	148	3	CID000038521
Drug	SB-273779	ADRA1D ADRA1B ADRA1A	2.20e-05	9	148	3	CID005311133
Drug	dapiprazole	ADRA1D ADRA1B ADRA1A	2.20e-05	9	148	3	CID003033538
Drug	p-menthane	ADRA1D ADRA1B ADRA1A	2.20e-05	9	148	3	CID000007459
Drug	adrafinil	ADRA1D ADRA1B ADRA1A	2.20e-05	9	148	3	CID003033226
Drug	Quetiapine	CHRM3 ADRA1D ADRA1B ADRA1A	2.29e-05	26	148	4	DB01224
Drug	ZD9331	GART CPT2 BIRC6 TMEM132D	3.11e-05	28	148	4	CID000213022
Drug	Norepinephrine	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	DB00368
Drug	trimazosin	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	CID000037264
Drug	L-659,066	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	CID000163952
Drug	Ergotamine	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	DB00696
Drug	azapetine	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	CID000008966
Drug	Droxidopa	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	DB06262
Drug	DO 710	ADRA1D ADRA1B ADRA1A	3.12e-05	10	148	3	CID003084985
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	KANSL1L CMKLR2 DSC3 AOX1 TFDP2 OTUB2 MCTP1 DOCK6	3.67e-05	191	148	8	3976_DN
Drug	17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A	KANSL1L NDNF HSPH1 TFDP2 PCIF1 SMARCD3 CACNG4 DOCK6	4.10e-05	194	148	8	1213_UP
Drug	St-1913	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000123528
Drug	Neldazosin	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000065908
Drug	DL-028	ADRA1B ADRA1A	4.20e-05	2	148	2	CID005487531
Drug	quinazosin	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000027486
Drug	hydroxyphenacetyl aminoclonidine	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000173558
Drug	Midodrine	ADRA1B ADRA1A	4.20e-05	2	148	2	DB00211
Drug	sulfonterol	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000170372
Drug	AC1L27FT	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000016192
Drug	paveril	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000006855
Drug	tolazine	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000101252
Drug	piclonidine	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000068914
Drug	Lidanserin	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000068919
Drug	FCE 22716	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000125720
Drug	SKF 101253	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000135152
Drug	ASL-7022	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000173406
Drug	hoquizil	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000030690
Drug	Methoxamine	ADRA1B ADRA1A	4.20e-05	2	148	2	DB00723
Drug	Prestwick_774	ADRA1B ADRA1A	4.20e-05	2	148	2	CID006420011
Drug	compound 44-549	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000191431
Drug	5-dembs	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000130379
Drug	levomepromazine sulfoxide	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000165566
Drug	R 56	ADRA1B ADRA1A	4.20e-05	2	148	2	CID009578362
Drug	dihydrolysergic acid amide	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000151000
Drug	St-404	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000191786
Drug	AC1MBW4N	ADRA1B ADRA1A	4.20e-05	2	148	2	CID002732234
Drug	Myordil	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000011282
Drug	5-cfmbs	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000183818
Drug	IK29	ADRA1B ADRA1A	4.20e-05	2	148	2	CID000183825
Disease	total lipids in small HDL measurement	MAP4K5 PCIF1 ANXA9 DOCK6	2.53e-05	35	144	4	EFO_0022311
Disease	cholesterol in small HDL measurement	MAP4K5 SBF2 PCIF1 ANXA9	2.84e-05	36	144	4	EFO_0022226
Disease	phospholipids in small HDL measurement	MAP4K5 PCIF1 ANXA9 DOCK6	3.53e-05	38	144	4	EFO_0022296
Disease	alcohol use disorder (implicated_via_orthology)	RYR3 ADRA1D ADRA1B ADRA1A MAP4K5 SMARCD2 SMARCD3	5.06e-05	195	144	7	DOID:1574 (implicated_via_orthology)
Disease	X-24309 measurement	EPHX2 ADRA1D ADRA1A	1.22e-04	20	144	3	EFO_0800872
Disease	response to hydroxyurea	ADRA1D ADRA1A	1.41e-04	4	144	2	GO_0072710
Disease	levulinate 4-oxovalerate measurement	ADRA1D ADRA1A	1.41e-04	4	144	2	EFO_0021024
Disease	ANGPTL8 measurement	MAP4K5 DOCK6	1.41e-04	4	144	2	EFO_0020861
Disease	polycystic ovary syndrome (biomarker_via_orthology)	ADRA1D ADRA1B ADRA1A	1.42e-04	21	144	3	DOID:11612 (biomarker_via_orthology)
Disease	Fever, Diarrhea, response to sulfasalazine	ADRA1D ADRA1A	3.50e-04	6	144	2	EFO_0008324, HP_0001945, HP_0002014
Disease	cholesterol in large HDL measurement	RILPL1 MAP4K5 PCIF1 DOCK6	6.45e-04	80	144	4	EFO_0021900
Disease	creatinine measurement, chronic kidney disease	TFDP2 MAP4K5 ANXA9	6.64e-04	35	144	3	EFO_0003884, EFO_0004518
Disease	free cholesterol in small HDL measurement	MAP4K5 PCIF1 DOCK6	6.64e-04	35	144	3	EFO_0022270
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCD2 SMARCD3	8.33e-04	9	144	2	DOID:1925 (implicated_via_orthology)
Disease	fetal genotype effect measurement, body weights and measures	DCST2 CHRM3 FGD5	1.78e-03	49	144	3	EFO_0004324, EFO_0007959
Disease	X-11444 measurement	SPAST BIRC6	1.78e-03	13	144	2	EFO_0021237
Disease	Tinnitus, response to cisplatin	ADRA1D ADRA1A	2.38e-03	15	144	2	GO_0072718, HP_0000360
Disease	glycerate measurement	RYR3 MCTP1	2.38e-03	15	144	2	EFO_0021029
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	TRAIP BIRC6 MAP4K5 SBF2 PCIF1 DOCK6	2.41e-03	276	144	6	EFO_0004612, EFO_0020943
Disease	creatinine measurement, glomerular filtration rate	TFDP2 MAP4K5 IZUMO1 ANXA9	2.63e-03	117	144	4	EFO_0004518, EFO_0005208
Disease	lung disease severity measurement	NEK10 ERVK13-1 RILPL1 CHRM3	2.71e-03	118	144	4	EFO_0007744
Disease	S-adenosylhomocysteine measurement	ADRA1D ADRA1A	3.07e-03	17	144	2	EFO_0010531
Disease	phospholipids in HDL measurement	MAP4K5 PCIF1 DOCK6	3.33e-03	61	144	3	EFO_0022293
Disease	total lipids in HDL measurement	MAP4K5 PCIF1 DOCK6	3.65e-03	63	144	3	EFO_0022307
Disease	pulmonary non-tuberculous mycobacterial infection	CHRM3 NUAK1	3.83e-03	19	144	2	MONDO_0018469
Disease	Tinnitus	SLFN12 RB1CC1 PTPN13 MINAR1	3.84e-03	130	144	4	HP_0000360
Disease	phosphatidylcholine 34:2 measurement	B3GALT5 GPBP1L1	4.24e-03	20	144	2	EFO_0010376
Disease	triglycerides in very small VLDL measurement	MAP4K5 PCIF1 IZUMO1	4.52e-03	68	144	3	EFO_0022144
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	MAP4K5 PCIF1	4.67e-03	21	144	2	EFO_0022277

Protein segments in the cluster

Peptide	Gene	Start	Entry
SKAKTRVFRDTAEPK	ABR	536	Q12979
SLTIFVDKRKLSKRA	BRINP3	146	Q76B58
TKFFLKEILRLGFKS	CFAP61	571	Q8NHU2
GKKFKIVRTFRIETR	EIF3G	76	O75821
KDILKRTKRFIFTLI	ERVK13-1	281	Q9NX77
VTIRRFKKTSISKER	BIRC6	1301	Q9NR09
HFSVRLLKFSREKKA	ADRA1A	256	P35348
ERARLKTVKFNSKTR	DLG1	651	Q12959
ASFALKKIKRSSIRK	GTPBP1	461	O00178
ERVASKVKERSLFKS	GPR33	226	Q49SQ1
LSFKEATLAKRFALK	CHRM3	456	P20309
LKKNRTTRFFTGFLK	B3GALT5	171	Q9Y2C3
RSSIAVKLFKFSREK	ADRA1B	276	P35368
RDRITSFRKSTVKKE	DIAPH2	56	O60879
EFEEFTRKLKVKRSS	EFCAB12	481	Q6NXP0
FKRRAKAFTQDKFSK	ARMCX4	2236	Q5H9R4
KVEFKRTLIISFLFK	AOX1	511	Q06278
AKSDTITFKRLIRFV	CPT2	181	P23786
STIIKDSRRVFRKKY	NBEAL1	1026	Q6ZS30
RKVTTVKKFFSASSR	RABGEF1	96	Q9UJ41
IDFRTRESTAKKIKA	RGS1	151	Q08116
KVTRAFSFSKTPKRA	ECT2	836	Q9H8V3
TKLKQETTFLAFKRT	INTS12	251	Q96CB8
SVLKIRSFSGRKKTF	OR5I1	226	Q13606
SATKKFKRSVLLSVD	KIAA1107	916	Q9UPP5
KLFSFVKKTLERELA	LRRC9	286	Q6ZRR7
KIEELSKRFTAIRKT	OTUB2	31	Q96DC9
EKSKRESFGKLFRKS	RB1CC1	531	Q8TDY2
ITSDKVGRKVFSKLR	FMOD	141	Q06828
KRKDRTRLKSSSLTF	KANSL1L	541	A0AUZ9
AKALLFEVKEIFRKS	ENTPD5	141	O75356
FIAVKTTKKFHRARL	LFNG	116	Q8NES3
FKKRKQVLDRVFSSS	MCTP1	81	Q6DN14
FKESLKVVLTRAFKD	MAS1	291	P04201
KAVARRAKLKFSTSE	KIAA0895	46	Q8NCT3
KTFRSSIKEKTVGRA	ITIH2	126	P19823
FRTFSKTIVKGAKRA	SBF2	1036	Q86WG5
RRTTDRKSEFLKTLK	GPBP1L1	316	Q9HC44
RKKKTRTVFSRSQVF	HMX3	226	A6NHT5
FRKFTKSERSKDLIK	PRKG1	81	Q13976
FLRDVTKRLATDKRF	ATAD2B	966	Q9ULI0
TKRLATDKRFNIFSK	ATAD2B	971	Q9ULI0
KTLASKRLAADRKLF	IPO11	156	Q9UI26
KERIAKFFGKDISTT	HSPH1	351	Q92598
FISSKFTRKIRFLDS	BNIPL	311	Q7Z465
SLKKKLRARSQLSEF	CTSE	31	P14091
AFVISRRRSKYSKAK	EPHA4	566	P54764
DKIIRTIFKRLKSFI	FSIP2	1261	Q5CZC0
LFSATFRKKIEKLAR	DDX42	436	Q86XP3
TKEFFRRSKIAVFDK	GRIA2	676	P42262
LKRRVIERFKKSLFS	NEK10	1056	Q6ZWH5
SSFKRFLALTFKKKT	FGD5	651	Q6ZNL6
KSSGFRKSFRLSRKD	MPP7	316	Q5T2T1
TDVFVKRKGAKFLRF	NDNF	351	Q8TB73
LFRTKFSLQKLKEIS	LCA5	196	Q86VQ0
RFVNLISERKTKFAK	LAS1L	121	Q9Y4W2
LSIRAEFRKKFGKSL	ANXA9	306	O76027
LAESRKKTERLAFRK	FAM120A	616	Q9NZB2
KRLTFSVTLKNKRES	ITGA2	821	P17301
VKIKVFRLFKFNSRD	OTULINL	311	Q9NUU6
FAKTFKQRRIKLGFT	POU2F1	291	P14859
EKFSKKLASSSFIRL	MEI1	591	Q5TIA1
SSEKRKKSQRLFFKN	FAM81B	11	Q96LP2
ERTKIFKRTAPSFTK	SCYL3	416	Q8IZE3
QKSSFFSLRRKSRSK	DGKG	776	P49619
FSIKEIFDKAISARK	EPHX2	86	P34913
SRIKFREEAKRLLFK	PCIF1	276	Q9H4Z3
KAFERINSLTFKKSL	DOCK6	1301	Q96HP0
TARAVALSDKKRSFT	DSC3	81	Q14574
SFSRRLIKRFSFKSK	C2CD2L	681	O14523
KELRFKTKREFLKAS	CACNG4	211	Q9UBN1
KVKSFTKRFIDNLRD	COL6A1	61	P12109
KKFVLSRRRAATFEA	DCDC2C	31	A8MYV0
SHSFKRSFLEKKRFT	APOL3	66	O95236
RSFLEKKRFTEEATK	APOL3	71	O95236
ASKFITKEKRRRISA	HOXC13	281	P31276
FFVRKKSSLRKSSLE	ESCO2	211	Q56NI9
RSSSRFIKRKKFDDE	MCRS1	46	Q96EZ8
RSRSGKFRLVTKFKK	DGKD	1111	Q16760
KFKEAERLFSKSSVT	MEAF6	81	Q9HAF1
RSSNTFSIKKIRFLV	DDX49	136	Q9Y6V7
AIFRRRKVIDFIKSS	IZUMO1	311	Q8IYV9
ARKTKEVADRVRKFF	DCST2	156	Q5T1A1
SKLSFREFLLIFRKA	EFHD2	146	Q96C19
LLRRKDGTVISTFKK	HDAC5	281	Q9UQL6
RRLKKKDFKSSLSLA	GRIP1	441	Q9Y3R0
SFIKLLRSKVSSFLR	SCUBE3	976	Q8IX30
TLKVTKKFRVVFEGR	MEP1B	391	Q16820
KALTSKTNRRFVKKF	DENND2D	411	Q9H6A0
KARFKRFGSAKVIRS	MLPH	126	Q9BV36
VAAKITATIAKRKSF	MAP4K5	161	Q9Y4K4
KKTKATVNFTLFFRI	PTPN13	646	Q12923
AKFFSRRAEEKIKSV	RPL27A	126	P46776
SESLRVKALKKSLFT	MINAR1	691	Q9UPX6
TKREKFKRSFKVRVS	RIN1	236	Q13671
VTKALTVRFLTKRFI	RERGL	16	Q9H628
KRKRVKFTTFTAVSS	TMEM132D	1041	Q14C87
FRTLSKVRSDKSLKF	DNTT	271	P04053
KSIRRKERKASVLFV	PWWP3B	411	Q5H9M0
LFKSFSVRSRKDLKD	PLCE1	1221	Q9P212
FLLTARRKDAKSVKI	RPL38	11	P63173
IKSLSKERRKTLETY	IQGAP2	871	Q13576
IDFKRLKEKRSSLVT	INSL6	196	Q9Y581
VSDFFKERTSFKERK	PLPP1	246	O14494
KTFLKRQAIKTAFRS	ERCC5	111	P28715
FSFLDKDSRKSLART	FBXL22	21	Q6P050
KQKRKFSSFFKSLVI	SMARCD3	196	Q6STE5
RKKFFEKKFTEISHR	RNF32	221	Q9H0A6
EDSFLKTKKLRTARR	SPATA16	541	Q9BXB7
FSGRVVAIKSIRKDK	NUAK1	76	O60285
FRVVSLKLLRTHFKK	SEC23IP	471	Q9Y6Y8
RLSDFTESLKKIKRS	SPAST	581	Q9UBP0
SVKKKSSRNIFSIVF	P2RY14	226	Q15391
KRARKFIDSDFSESK	TFDP2	106	Q14188
IDNKLRRYTTFSKRK	SRF	151	P11831
KRKFSSFFKSLVIEL	SMARCD2	246	Q92925
SSLSVRLLKFSREKK	ADRA1D	331	P25100
FKVKKRSILISSRHF	CMKLR2	231	P46091
KTSLKAATIKAEFVR	CILP	291	O75339
RKRVSEKNKRDFSAF	CNNM4	521	Q6P4Q7
FKLRSKTSCANLKRF	RAPGEF2	746	Q9Y4G8
ASITERRKKGSFFIS	PLCXD3	231	Q63HM9
RSLFAKVTKSLFGRK	PLK3	341	Q9H4B4
RIVFEKKLRIKSSFV	SERPINF1	141	P36955
KDRKTNKSRGFAFVT	RBMXL3	41	Q8N7X1
SGIKRLFSFFSRDKK	RILPL1	351	Q5EBL4
IKFSSSDRKKQREFE	TCERG1	991	O14776
KADFRTLLKETKFIT	TCERG1	1016	O14776
TAFSFRASKELKEKL	RYR3	316	Q15413
TLTAVRKFTKRDVFL	POLR2A	541	P24928
SVREASFVKKRKLRV	ZNF587	151	Q96SQ5
RKLSTFRESFKKRVI	SP100	386	P23497
LKRSLSFKTKSLRSK	STAC	41	Q99469
KSIFVQKKRRSSAVD	SFMBT2	696	Q5VUG0
SVREASFVKKRKLRV	ZNF417	151	Q8TAU3
FRRLASVASKLKEFI	PIEZO2	201	Q9H5I5
KALKRLKSLRDQFSF	SLFN12	536	Q8IYM2
KVSLFERVTGKKDSR	RAB11FIP2	356	Q7L804
RKRAKLISTVSKKDF	RRP15	196	Q9Y3B9
FSFEKKKARVAVLIS	GART	801	P22102
FFLKVSELFDKTRKI	SNX6	266	Q9UNH7
KSFFKRKTILFIDEI	WRNIP1	316	Q96S55
SKKSVLREKLRYAIS	UBE3B	1046	Q7Z3V4
SKFVKEFLGRRSSKD	WNT9A	176	O14904
SGKEKRSFSKRLFRS	USP31	16	Q70CQ4
LRKKTETFSTRRVKS	WDR27	251	A2RRH5
FRRFILASKLKSEIK	TEX2	701	Q8IWB9
VFFAIKERKKATSRE	SLC5A12	26	Q1EHB4
RVLKFFTKLFQLTEK	UBR4	1426	Q5T4S7
LEKRKETTKRHLFFT	TRRAP	3556	Q9Y4A5
SFSESLRKLCVFKKI	XRCC5	226	P13010
VADKLRKDLFSSRSK	TRAIP	221	Q9BWF2
KAENIKSFLRSFTKL	NAALAD2	56	Q9Y3Q0